Text size: 
Archived: Menopausal Hormone Therapy: Preventive Medication
Original Release Date: October 2012
This version of this topic is currently archived and inactive. It should be used for historical purposes only.
Archived: Recommendation Summary
Summary of Recommendations and Evidence
| Population | Recommendation | Grade (What's This?) |
|---|---|---|
| Postmenopausal Women | The USPSTF recommends against the use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women. | D |
| Postmenopausal Women, Who Have Had a Hysterectomy | The USPSTF recommends against the use of estrogen for the prevention of chronic conditions in postmenopausal women who have had a hysterectomy. | D |
This recommendation applies only to postmenopausal women who are considering hormone therapy for the primary prevention of chronic medical conditions. This is not a recommendation about the use of hormone therapy to treat menopausal symptoms, such as hot flashes or vaginal dryness; the USPSTF did not review the evidence related to this possible indication because it falls outside of the mission and scope of the USPSTF. This recommendation also does not apply to women younger than 50 years who have had surgical menopause.
Internet Citation: Final Update Summary: Menopausal Hormone Therapy: Preventive Medication. U.S. Preventive Services Task Force. September 2016.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/menopausal-hormone-therapy-preventive-medication